Abstract:BACKGROUND Heart failure (HF) is one of the many cardiovascular epidemics that plague the world. It has a prevalence of about 40 million people globally and about 1.5% of the United States population. HF has been documented to be the leading cause of death in adults with congenital heart diseases (CHD), described in 26% of all deaths in a national registry of >8000 adults with CHD. This study dives deep into the in-hospital outcomes of patients admitted for HF with a history of CHD. METHOD This was a retrospective study done using patient records from the 2016-2020 National In-patient Database (NIS). We identified patients who were admitted for HF with a history of CHD, evaluated their associated socio-demographic and comorbid factors using (International Classification of Diseases- 10) ICD-10 codes. We excluded patients under 18 years of age. We utilized the chi-square test to compare baseline characteristics between our populations with and without a history of CHD and further performed multivariate logistic regression to identify outcomes. RESULTS The study analyzed a total of 1,372,419 patients with HF, out of which 10,315 individuals (1.3%) had a past medical history of CHD. The results revealed that patients with a history of CHD were significantly younger, with a mean age of 60 years compared to 70 years in those without CHD. Our population with a history of CHD had a higher rates of acute kidney injuries (32.2% vs 25.9%, p<0.0001), prior history of a cardiovascular accident (1.6% vs 0.4%, p<0.0001), liver disease (16.7% vs 6.6%, p<0.0001), electrolyte abnormalities (39.8% vs 32%, p< 0.0001), Anemia (33.7% vs 31.3%, p=0.017) and had a Charlson comorbidity index ≥3 (p<0.0001). Although the prevalence of HF in patients with CHD has decreased in recent years (from 4.9% - 1% between 2016 - 2020), in-hospital mortality rates remain high [adjusted Odd Ratio (aOR): 1.32, CI 1.0 - 1.66, p=0.023] The results of our study demonstrated that the population with a history of CHD had increased rates of cardiogenic shock (aOR: 1.32, CI: 1.1 - 1.7, p=0.005), respiratory failure (aOR: 1.3, CI:1.2 - 1.4, p<0.001), and a higher likelihood of using Mechanical Circulatory support devices (aOR: 2.7, CI: 1.03 - 3.58, p<0.001). Moreover, the CHD group had a longer mean length of hospital stay (9.7 days vs 5.4 days, p<0.0001) and incurred higher total hospital costs ($153,551.1 vs $53,169.8, p<0.0001). CONCLUSION Individuals with HF who also have a history of CHD experience poorer outcomes compared to those without CHD due to a range of intrinsic and extrinsic factors, such as the presence of structural abnormalities or additional cardiovascular conditions. Therefore, it is crucial to focus on preserving myocardial function throughout the individual's lifespan to mitigate the negative impact of these factors.

Adults with Congenital Heart Disease (ACHD)

Adults With Congenital Heart Disease—a New, Expanding Group of Patients

Complex Congenital Heart Disease in the Adult

Challenges in the Diagnosis of Adult Congenital Heart Diseases

Adults With Congenital Heart Disease: Trends in Event-Free Survival Past Middle Age

Emerging Research Directions in Adult Congenital Heart Disease: A Report From an NHLBI/ACHA Working Group

Transitional Care for Adult Patients with Congenital Heart Disease: A Review

Pharmacological management of heart failure in adults with congenital heart disease

Congenitally corrected transposition of the great arteries in the adult: Functional status and complications

The Pathophysiology(ies) of Heart Failure in Adults with Congenital Heart Disease

Adult Congenital Heart Disease in the Emergency Department

Heart Failure In Adults With History Of Congenital Heart Disease

[Organizational and medical aspects of transition of juveniles with congenital heart defects to adult cardiology care]

Adult Congenital Heart Disease: Report from a Public Reference Hospital in Northeastern Brazil

Surveillance of adults with congenital heart disease: Current guidelines and actual clinical practice

The Transition of Children Living With Congenital Heart Disease to Adult Care

Congenital heart disease: types, pathophysiology, diagnosis, and treatment options

Cardiac Drugs in ACHD Cardiovascular Medicine

Impact of Social Determinants of Health on Outcomes for Patients with Adult Congenital Heart Disease

PATHFINDER-CHD: prospective registry on adults with congenital heart disease, abnormal ventricular function, and/or heart failure as a foundation for establishing rehabilitative, prehabilitative, preventive, and health-promoting measures: rationale, aims, design and methods

Twenty-Seven-Year Institutional Experience With Surgery for Adults With Congenital Heart Disease